These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16175507)

  • 1. A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors.
    Duan QL; Nikpoor B; Dube MP; Molinaro G; Meijer IA; Dion P; Rochefort D; Saint-Onge J; Flury L; Brown NJ; Gainer JV; Rouleau JL; Agostoni A; Cugno M; Simon P; Clavel P; Potier J; Wehbe B; Benarbia S; Marc-Aurele J; Chanard J; Foroud T; Adam A; Rouleau GA
    Am J Hum Genet; 2005 Oct; 77(4):617-26. PubMed ID: 16175507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema.
    Woodard-Grice AV; Lucisano AC; Byrd JB; Stone ER; Simmons WH; Brown NJ
    Pharmacogenet Genomics; 2010 Sep; 20(9):532-6. PubMed ID: 20625347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor-induced angioedema.
    Cilia La Corte AL; Carter AM; Rice GI; Duan QL; Rouleau GA; Adam A; Grant PJ; Hooper NM
    Hum Mutat; 2011 Nov; 32(11):1326-31. PubMed ID: 21898657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinin-dependent hypersensitivity reactions in hemodialysis: metabolic and genetic factors.
    Molinaro G; Duan QL; Chagnon M; Moreau ME; Simon P; Clavel P; Lavaud S; Boileau G; Rouleau GA; Lepage Y; Adam A; Chanard J
    Kidney Int; 2006 Nov; 70(10):1823-31. PubMed ID: 17003818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exome Sequencing Reveals Common and Rare Variants in F5 Associated With ACE Inhibitor and Angiotensin Receptor Blocker-Induced Angioedema.
    Maroteau C; Siddiqui MK; Veluchamy A; Carr F; White M; Cassidy AJ; Baranova EV; Rasmussen ER; Eriksson N; Bloch KM; Brown NJ; Bygum A; Hallberg P; Karawajczyk M; Magnusson PKE; Yue QY; Syvänen AC; von Buchwald C; Alfirevic A; Maitland-van der Zee AH; Wadelius M; Palmer CNA;
    Clin Pharmacol Ther; 2020 Dec; 108(6):1195-1202. PubMed ID: 32496628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of ACE inhibitor-induced angioedema identifies novel risk locus.
    Mathey CM; Maj C; Eriksson N; Krebs K; Westmeier J; David FS; Koromina M; Scheer AB; Szabo N; Wedi B; Wieczorek D; Amann PM; Löffler H; Koch L; Schöffl C; Dickel H; Ganjuur N; Hornung T; Buhl T; Greve J; Wurpts G; Aygören-Pürsün E; Steffens M; Herms S; Heilmann-Heimbach S; Hoffmann P; Schmidt B; Mavarani L; Andresen T; Sørensen SB; Andersen V; Vogel U; Landén M; Bulik CM; ; ; Bygum A; Magnusson PKE; von Buchwald C; Hallberg P; Rye Ostrowski S; Sørensen E; Pedersen OB; Ullum H; Erikstrup C; Bundgaard H; Milani L; Rasmussen ER; Wadelius M; Ghouse J; Sachs B; Nöthen MM; Forstner AJ
    J Allergy Clin Immunol; 2024 Apr; 153(4):1073-1082. PubMed ID: 38300190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of a novel molecular assay examining the role of aminopeptidase P polymorphisms in acute hypotensive transfusion reactions.
    Hui Y; Wu Y; Tormey CA
    Arch Pathol Lab Med; 2013 Jan; 137(1):96-9. PubMed ID: 23276181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.
    Gulec M; Caliskaner Z; Tunca Y; Ozturk S; Bozoglu E; Gul D; Erel F; Kartal O; Karaayvaz M
    Allergol Immunopathol (Madr); 2008; 36(3):134-40. PubMed ID: 18680700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment.
    Rasmussen ER; Hallberg P; Baranova EV; Eriksson N; Karawajczyk M; Johansson C; Cavalli M; Maroteau C; Veluchamy A; Islander G; Hugosson S; Terreehorst I; Asselbergs FW; Norling P; Johansson HE; Kohnke H; Syvänen AC; Siddiqui MK; Lang CC; Magnusson PKE; Yue QY; Wadelius C; von Buchwald C; Bygum A; Alfirevic A; Maitland-van der Zee AH; Palmer CNA; Wadelius M
    Pharmacogenomics J; 2020 Dec; 20(6):770-783. PubMed ID: 32080354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic susceptibility to angiotensin-converting enzyme-inhibitor induced angioedema: A systematic review and evaluation of methodological approaches.
    Ali HA; Lomholt AF; Mahmoudpour SH; Hermanrud T; Bygum A; von Buchwald C; Jakobsen MA; Rasmussen ER
    PLoS One; 2019; 14(11):e0224858. PubMed ID: 31710633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute adverse reactions associated with angiotensin-converting enzyme inhibitors: genetic factors and therapeutic implications.
    Nikpoor B; Duan QL; Rouleau GA
    Expert Opin Pharmacother; 2005 Sep; 6(11):1851-6. PubMed ID: 16144506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema.
    Blais C; Rouleau JL; Brown NJ; Lepage Y; Spence D; Munoz C; Friborg J; Geadah D; Gervais N; Adam A
    Immunopharmacology; 1999 Sep; 43(2-3):293-302. PubMed ID: 10596866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics of angiotensin-converting enzyme inhibitor-induced angioedema.
    Liau Y; Chua I; Kennedy MA; Maggo S
    Clin Exp Allergy; 2019 Feb; 49(2):142-154. PubMed ID: 30537422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of Factor XII and bradykinin catabolic enzymes in a family with estrogen-dependent inherited angioedema.
    Duan QL; Binkley K; Rouleau GA
    J Allergy Clin Immunol; 2009 Apr; 123(4):906-10. PubMed ID: 19178938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors as a cause of isolated angioedema in a Slovenian population.
    Zupanc C; Košnik M
    Acta Dermatovenerol Alp Pannonica Adriat; 2016; 25(1):1-4. PubMed ID: 27014771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics of ACE inhibitor-induced angioedema and cough: a systematic review and meta-analysis.
    Mahmoudpour SH; Leusink M; van der Putten L; Terreehorst I; Asselbergs FW; de Boer A; Maitland-van der Zee AH
    Pharmacogenomics; 2013 Feb; 14(3):249-60. PubMed ID: 23394388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief review: angiotensin converting enzyme inhibitors and angioedema: anesthetic implications.
    Sarkar P; Nicholson G; Hall G
    Can J Anaesth; 2006 Oct; 53(10):994-1003. PubMed ID: 16987854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of icatibant on angiotensin-converting enzyme inhibitor-induced angioedema: A meta-analysis of randomized controlled trials.
    Jeon J; Lee YJ; Lee SY
    J Clin Pharm Ther; 2019 Oct; 44(5):685-692. PubMed ID: 31290163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedema.
    Lefebvre J; Murphey LJ; Hartert TV; Jiao Shan R; Simmons WH; Brown NJ
    Hypertension; 2002 Feb; 39(2 Pt 2):460-4. PubMed ID: 11882590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off-Label Use of Agents for Management of Serious or Life-threatening Angiotensin Converting Enzyme Inhibitor-Induced Angioedema.
    Culley CM; DiBridge JN; Wilson GL
    Ann Pharmacother; 2016 Jan; 50(1):47-59. PubMed ID: 26416949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.